Coagulation and fibrinolysis in inflammatory bowel disease and in giant cell arteritis.

Background: In inflammatory bowel disease (IBD), gut microvascular thrombosis as well as thromboembolic complications have repeatedly been observed. We examined the long-term course of markers of coagulation and fibrinolysis in relation to clinical disease activity.

Materials And Methods: In a prospective study, prothrombin fragment 1 and 2 (F1.